Catherine A Bourg

Summary

Affiliation: University of Georgia
Country: USA

Publications

  1. doi request reprint Rosiglitazone, myocardial ischemic risk, and recent regulatory actions
    Catherine A Bourg
    PGY2 Ambulatory Care Resident, University of Georgia, Athens, USA
    Ann Pharmacother 46:282-9. 2012

Detail Information

Publications1

  1. doi request reprint Rosiglitazone, myocardial ischemic risk, and recent regulatory actions
    Catherine A Bourg
    PGY2 Ambulatory Care Resident, University of Georgia, Athens, USA
    Ann Pharmacother 46:282-9. 2012
    ..To review the evidence surrounding rosiglitazone and ischemic cardiovascular risk and discuss the Food and Drug Administration (FDA) decision to revise safety information and restrict access to the drug...